Florida Senate - 2016 SENATOR AMENDMENT Bill No. CS/HB 1187, 1st Eng. Ì409732+Î409732 LEGISLATIVE ACTION Senate . House . . . Floor: WD . 03/10/2016 04:48 PM . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— Senator Brandes moved the following: 1 Senate Amendment (with title amendment) 2 3 Between lines 1130 and 1131 4 insert: 5 Section 40. The Office of Program Policy Analysis and 6 Government Accountability (OPPAGA) shall submit to the Governor, 7 the President of the Senate, and the Speaker of the House of 8 Representatives by December 1, 2016, a report and 9 recommendations on the effectiveness and funding self 10 sufficiency of the cosmetic product and facility regulatory 11 activities of the Division of Drugs, Devices, and Cosmetics 12 within the Department of Business and Professional Regulation. 13 This report shall include input from cosmetic manufacturers in 14 the state, as well as an examination and assessment of the 15 division’s consistency of application and enforcement of state 16 laws and rules, and the regulations and guidance of the United 17 States Food and Drug Administration related to cosmetic products 18 and facilities. 19 20 ================= T I T L E A M E N D M E N T ================ 21 And the title is amended as follows: 22 Delete line 139 23 and insert: 24 adopt rules; requiring the Office of Program Policy 25 Analysis and Government Accountability to submit a 26 certain report to the Governor and the Legislature by 27 a certain date; providing requirements for the report; 28 providing an effective date.